12:00 AM
 | 
Nov 22, 1999
 |  BC Week In Review  |  Company News  |  Deals

Sunol, Novo Nordisk deal

Novo Nordisk received an exclusive worldwide license to Sunol's small molecule Tissue Factor antagonists and additional exclusive...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >